Cargando…

CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas

CD24 is overexpressed in glioma cells in vitro and in vivo. However, the correlation of its expression with clinicopathological parameters of gliomas and its prognostic significance in this tumor remain largely unknown. To address this problem, 151 glioma specimens and 10 nonneoplastic brain tissues...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Jianping, Gao, Guodong, Wang, Liang, Wang, Tao, Yu, Jia, Zhao, Zhenwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303885/ https://www.ncbi.nlm.nih.gov/pubmed/22500096 http://dx.doi.org/10.1155/2012/517172

Ejemplares similares

Oncogenic reg IV is a novel prognostic marker for glioma patient survival
por: Wang, Qi, et al.
Publicado: (2012)

CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer
por: TANAKA, TOMOHITO, et al.
Publicado: (2015)

The neural stem-cell marker CD24 is specifically upregulated in IDH-mutant glioma
por: Tiburcio, Patricia D.B., et al.
Publicado: (2020)

Identification of CD24 as a marker for tumorigenesis of melanoma
por: Tang, Ming-Rui, et al.
Publicado: (2018)

CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma
por: Agrawal, Shefali, et al.
Publicado: (2007)

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
por: Zhang, Mingyu, et al.
Publicado: (2008)

CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma
por: Alaterre, Elina, et al.
Publicado: (2017)

High ECM2 Expression Predicts Poor Clinical Outcome and Promotes the Proliferation, Migration, and Invasiveness of Glioma
por: Li, Junsheng, et al.
Publicado: (2023)

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
por: Jia, Yulong, et al.
Publicado: (2022)

Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019)

Clinical Value of CD24 Expression in Retinoblastoma
por: Li, Jia, et al.
Publicado: (2012)

New Enhancement beyond Radiation Field Improves Survival Prediction in Patients with Post-Treatment High-Grade Glioma
por: Yuan, Tao, et al.
Publicado: (2021)

CD24: a marker of granulosa cell subpopulation and a mediator of ovulation
por: Dong, Jun-peng, et al.
Publicado: (2019)

CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
por: Nakamura, Kiyoko, et al.
Publicado: (2017)

Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016)

Early Expression of Functional Markers on CD4(+) T Cells Predicts Outcomes in ICU Patients With Sepsis
por: Chen, Jianwei, et al.
Publicado: (2022)

The CD2–CD58 axis: A novel marker predicting poor prognosis in patients with low‐grade gliomas and potential therapeutic approaches
por: Wu, Mingwei, et al.
Publicado: (2023)

Erratum to: Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas
por: Wu, Xing, et al.
Publicado: (2016)

Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis
por: Du, Zhanxin, et al.
Publicado: (2022)

CD133 Is a Marker of Bioenergetic Stress in Human Glioma
por: Griguer, Corinne E., et al.
Publicado: (2008)

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
por: Cao, Xueyuan, et al.
Publicado: (2014)

Relative T2-FLAIR signal intensity surrounding residual cavity is associated with survival prognosis in patients with lower-grade gliomas
por: Yuan, Tao, et al.
Publicado: (2022)

Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
por: Jaggupilli, Appalaraju, et al.
Publicado: (2012)

Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas
por: Wang, Liang, et al.
Publicado: (2012)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

Expression profiles and function prediction of tRNA-derived fragments in glioma
por: Wei, Deng, et al.
Publicado: (2023)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Expression of Concern: Identification of CD24 as a Cancer Stem Cell Marker in Human Nasopharyngeal Carcinoma
Publicado: (2019)

Lower expression of Bax predicts poor clinical outcome in patients with glioma after curative resection and radiotherapy/chemotherapy
por: Wang, Pei-Guo, et al.
Publicado: (2018)

CD34 Over-Expression is Associated With Gliomas’ Higher WHO Grade
por: Kong, Xiangyi, et al.
Publicado: (2016)

CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival
por: Gross Even-Zohar, Noa, et al.
Publicado: (2022)

Tumor mutational burden is associated with poor outcomes in diffuse glioma
por: Wang, Lihong, et al.
Publicado: (2020)

CD24(+)/CD38(-) as new prognostic marker for non-small cell lung cancer
por: Karimi-Busheri, Feridoun, et al.
Publicado: (2013)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer
por: Deng, Xinyu, et al.
Publicado: (2017)

New Autophagy-Ferroptosis Gene Signature Predicts Survival in Glioma
por: Zhou, Liwei, et al.
Publicado: (2021)

Expression of CD44 and the survival in glioma: a meta-analysis
por: Wu, Gang, et al.
Publicado: (2020)

Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells
por: Haddock, Sara, et al.
Publicado: (2022)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

Identification of CD24 as a Cancer Stem Cell Marker in Human Nasopharyngeal Carcinoma
por: Yang, Chun-Hung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i01qcbvdh7lv8aenkir7qj50fu